Cargando…
Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort
BACKGROUND: : Systemic immunosuppressive treatments are central in the treatment of severe atopic dermatitis (AD). Yet, comparative data are sparse on the performance of such immunosuppressive treatments in pediatric cohorts with severe AD. OBJECTIVE: : This study aimed to examine the drug survival...
Autores principales: | Elsgaard, Stine, Danielsen, Anna Kathrine, Thyssen, Jacob P., Deleuran, Mette, Vestergaard, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714597/ https://www.ncbi.nlm.nih.gov/pubmed/35028369 http://dx.doi.org/10.1016/j.ijwd.2021.07.005 |
Ejemplares similares
-
Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature
por: Heilskov, Sofine, et al.
Publicado: (2020) -
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study
por: Riis, Jette Lindorff, et al.
Publicado: (2016) -
Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry
por: LARSEN, Henrik H. P., et al.
Publicado: (2022) -
Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results
por: Nygaard, Uffe, et al.
Publicado: (2016) -
The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis
por: ELSNER, Julie Sophie Hohwü, et al.
Publicado: (2020)